Activation of serotonin 1A receptors in ventrolateral orbital cortex depresses persistent nociception: A presynaptic inhibition mechanism

Neurochemistry International

Volumn 57, Issue 7, 2010, Pages 749-755

  Huo, Fu Quan ^a   Huang, Fen Sheng ^a   Lv, Bo Chang ^b   Chen, Tao ^b   Feng, Jie ^a   Qu, Chao Ling ^a   Tang, Jing Shi ^a   Li, Yun Qing ^b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

5 HT1A receptor; Antinociception; Formalin test; Fos; MIPSCs; Ventrolateral orbital cortex

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; FORMALDEHYDE; GABAERGIC RECEPTOR AFFECTING AGENT; PROTEIN FOS;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN NERVE CELL; IMMUNOHISTOCHEMISTRY; INHIBITORY POSTSYNAPTIC POTENTIAL; LUMBAR SPINAL CORD; MALE; NOCICEPTION; NONHUMAN; ORBITAL CORTEX; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN; VENTROLATERAL ORBITAL CORTEX;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; CEREBRAL CORTEX; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; NEURAL INHIBITION; PAIN MEASUREMENT; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; SPINAL CORD;

RATTUS;

EID: 77958085252     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.08.011     Document Type: Article

References (56)

1. Abbadie C., Taylor B.K., Peterson M.A., Basbaum A.I. Differential contribution of the two phases of the formalin test to the pattern of c-Fos expression in the rat spinal cord: studies with remifentanil and lidocaine. Pain 1997, 69:101-110.
2. Abbott F.V., Ocvirk R., Najafee R., Franklin K.B. Improving the efficiency of the formalin test. Pain 1999, 83:561-569.
3. Aghajanian G.K. Electrophysiology of serotonin receptor subtypes and signal transduction pathways. Psychopharmacology: The Fourth Generation of Progress 1995, 1451-1459. Raven, New York. F.R. Bloom, D.G. Kupfer (Eds.).
4. Albert P.R., Lembo P., Storring J.M., Charest A., Saucier C. The 5-HT1A receptor: signaling, desensitization, and gene transcription. Neuropsychopharmacology 1997, 14:19-25.
5. Bardin L., Tarayre J.P., Koek W., Colpaert F.C. In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia. Eur. J. Pharmacol. 2001, 421:109-114.
6. Bardin L., Tarayre J.P., Malfetes N., Koek W., Colpaert F.C. Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain. Pharmacology 2003, 67:182-194.
7. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
8. Buritova J., Larrue S., Aliaga M., Besson J.M., Colpaert F. Effects of the high-efficacy 5-HT1A receptor agonist, F 13640 in the formalin pain model: a c-Fos study. Eur. J. Pharmacol. 2005, 514:121-130.
9. Centurión D., Mehotra S., Sánchez-López A., Gupta S., MaassenVanDenBrink A., Villalón C.M. Potential vascular α1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat. Eur. J. Pharmacol. 2006, 535:234-242.
10. Chapman V., Besson J.M. Pharmacological studies of nociceptive systems using the c-Fos immunohistochemical technique: an indicator of noxiously activated spinal neurons. Handbook of Experimental Pharmacology, The Pharmacology of Pain 1997, vol. 130:235-279. Springer-Verlag, Berlin Heidelberg.
11. Colpaert F.C. 5-HT(1A) receptor activation: new molecular and neuroadaptive mechanisms of pain relief. Curr. Opin. Investig. Drugs 2006, 7:40-47.
12. Colpaert F.C., Deseure K., Stinus L., Adriaensen H. High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning. J. Pharmacol. Exp. Ther. 2006, 316:892-899.
13. Deseure K., Bréand S., Colpaert F.C. Curative-like analgesia in a neuropathic pain model: parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT(1A) receptor agonist. Eur. J. Pharmacol. 2007, 568:134-141.
14. Fasmer O.B., Berge O.G., Post C., Hole K. Effects of the putative 5HT1A receptor agonist 8-OH-2-(di-n-propylamino)-tetralin on nociceptive sensitivity in mice. Pharmacol. Biochem. Behav. 1986, 25:883-888.
15. 2-adrenoceptors in the guinea pig. NeuroReport 2009, 20:325-330.
16. Harris J.A. Using c-fos as a neural marker of pain. Brain Res. Bull. 1998, 45:1-8.
17. Hossein K.K., Marie-Christine M., Marie-Jeanne B., Genevieve D., Mustapha R., Salah E.M., Michel H., Daniel V. Immunocytochemical location of seretonin1A receptors in the rat central nervous system. J. Comp. Neurol. 1996, 365:289-305.
18. Huang F.S., Meng K., Tang J.S. Properties of paired-pulse firing thresholds and the relationship with paired-pulse plasticity in hippocampal CA3-CA1 synapses. Eur. J. Neurosci. 2007, 25:3253-3263.
19. Huo F.Q., Qu C.L., Li Y.Q., Tang J.S., Jia H. GABAergic modulation is involved in the ventrolateral orbital cortex 5-HT1A receptor activation-induced antinociception in the rat. Pain 2008, 139:398-405.
20. Huo F.Q., Chen T., Lv B.C., Wang J., Zhang T., Qu C.L., Li Y.Q., Tang J.S. Synaptic connections between GABAergic elements and serotonergic terminals or projecting neurons in the ventrolateral orbital cortex. Cereb. Cortex 2009, 19:1263-1272.
21. Jeong H.J., Chenu D., Johnson E.E., Connor M., Vaughan C.W. Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol. Pain 2008, 4:54.
22. Jinks S.L., Simons C.T., Dessirier J.M., Carstens M.I., Antognini J.F., Carstens E. C-fos induction in rat superficial dorsal horn following cutaneous application of noxious chemical or mechanical stimuli. Exp. Brain Res. 2002, 145:261-269.
23. Kishimoto K., Koyama S., Akaike N. Presynaptic modulation of synaptic gamma-aminobutyric acid transmission by tandospirone in rat basolateral amygdala. Eur. J. Pharmacol. 2000, 407:257-265.
24. Kishimoto K., Koyama S., Akaike N. Synergistic μ-opioid and 5-HT1A presynaptic inhibition of GABA release in rat periaqueductal gray neurons. Neuropharmacology 2001, 41:529-538.
25. Kiss I., Degryse A.D., Bardin L., Gomez de Segura I.A., Colpaert F.C. The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain. Eur. J. Pharmacol. 2005, 523:29-39.
26. Koyama S., Kubo C., Rhee J.S., Akaike N. Presynaptic serotoninergic inhibition of GABAergic synaptic transmission in mechanically dissociated rat basolateral amygdala neurons. J. Physiol. 1999, 518:525-538.
27. Koyama S., Matsumoto N., Murakami N., Kubo C., Nabekura J., Akaike N. Role of presynaptic 5-HT1A and 5-HT3 receptors in modulation of synaptic GABA transmission in dissociated rat basolateral amygdala neurons. Life Sci. 2002, 72:375-387.
28. Li Y.Q., Takada M., Matsuzaki S., Shinonaga Y., Mizuno Identification of periaqueductal gray and dorsal raphe nucleus neurons projecting to both trigeminal sensory complex and forebrain structures: a fluorescent retrograde double-labeling study in the rat. Brain Res. 1993, 623:267-277.
29. Lu F., Tang J.S., Yuan B., Jia H. Effects of bilateral lesions of ventrolateral orbital cortex on the rat tail flick reflex inhibition evoked by electroacupuncture. Acupuncture Res. 1996, 21:39-42.
30. Luo C., Chen J., Li H.L., Li J.S. Spatial and temporal expression of c-Fos protein in the spinal cord of anesthetized rat induced by subcutaneous bee venom injection. Brain Res. 1998, 806:175-185.
31. Matsuzaki S., Takada M., Li Y.Q., Tokuno H., Mizuno N. Serotoninergic projections from the dorsal raphe nucleus to the nucleus submedius in the rat and cat. Neuroscience 1993, 55:403-416.
32. Millan M.J., Seguin L., Honore P., Girardon S., Bervoets K. Pro and antinociceptive actions of serotonin: 5HT1A, agonists and antagonists in rodents: relationship to algesiometric paradigm. Behav. Brain Res. 1996, 73:69-77.
33. Molander C., Xu Q., Grant G. The cytoarchitectonic organization of the spinal cord in the rat: 1. The lower thoracic and lumbosacral cord. J. Comp. Neurol. 1984, 230:133-141.
34. Nogueira R.L., Graeff F.G. Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion. Pharmacol. Biochem. Behav. 1995, 52:1-6.
35. Okuda K., Sakurada C., Takahashi M., Yamada T., Sakurada T. Characterization of nociceptive responses and spinal releases of nitric oxide metabolites and glutamate evoked by different concentrations of formalin in rats. Pain 2001, 92:107-115.
36. Oyama T., Ueda M., Kuraishi Y., Akaike A., Satoh M. Dual effect of serotonin on formalin-induced nociception in the rat spinal cord. Neurosci. Res. 1996, 25:129-135.
37. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, Sydney. 2nd ed.
38. Qu C.L., Tang J.S., Jia H. Involvement of GABAergic modulation of antinociception induced by morphine microinjection into the ventrolateral orbital cortex. Brain Res. 2006, 1073-1074:281-289.
39. Qu C.L., Huo F.Q., Huang F.S., Li Y.Q., Tang J.S., Jia H. The role of 5-HT receptor subtypes in the ventrolateral orbital cortex of 5-HT-induced antinociception in the rat. Neuroscience 2008, 152:487-494.
40. Seamans J.K., Gorelova N., Durstewitz D., Yang C.R. Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J. Neurosci. 2001, 21:3628-3638.
41. Susana A., Zhao X.Q., Reshma S., Birgitte R., Gitte M.K. The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res. 2003, 959:58-67.
42. Shannon H.E., Lutz E.A. Yohimbine produces antinociception in the formalin test in rats: involvement of serotonin 1A receptors. Psychopharmacology 2000, 149:93-97.
43. Tang J.S., Qu C.L., Huo F.Q. The thalamic nucleus submedius and ventrolateral orbital cortex are involved in nociceptive modulation: a novel pain modulation pathway. Prog. Neurobiol. 2009, 89:383-389.
44. Thompson S.M., Capogna M., Scanziani M. Presynaptic inhibition in the hippocampus. Trends Neurosci. 1993, 16:222-227.
45. Villalobos-Molina R., Lopez-Guerrero J.J., Gallardo-Ortiz I.A., Ibarra M. Evidence that the hypotensive effect of WAY 100635, a 5-HT1A receptor antagonist, is related to vascular alpha 1-adrenoceptor blockade in the adult rat. Auton. Autacoid. Pharmacol. 2002, 22:171-176.
46. Watanabe C., Okuda K., Sakurada C., Ando R., Sakurada T., Sakurada S. Evidence that nitric oxide-glutamate cascade modulates spinal antinociceptive effect of morphine: a behavioral and microdialysis study in rats. Brain Res. 2003, 990:77-86.
47. Willis W.D., Coggeshall R.E. Sensory Mechanisms of the Spinal Cord 2004, Kluwer Academic/Plenum publishers, New York, 271 pp. 3rd ed.
48. Xie Y.F., Wang J., Huo F.Q., Jia H., Tang J.S. Mu but not delta and kappa opioid receptor involvement in ventrolateral orbital cortex opioid-evoked antinociception in formalin test rats. Neuroscience 2004, 126:717-726.
49. 1-adrenoceptor subtypes. Jpn. J. Pharmacol. 2001, 86:189-195.
50. Zhang Y.Q., Tang J.S., Yuan B., Jia H. Inhibitory effects of electrical stimulation of thalamic nucleus submedius area on the rat tail flick reflex. Brain Res. 1995, 696:205-212.
51. Zhang Y.Q., Tang J.S., Yuan B., Jia H. Inhibitory effects of electrically evoked activation of ventrolateral orbital cortex on the tail-flick reflex are mediated by periaqueductal gray in rats. Pain 1997, 72:127-135.
52. Zhang S., Tang J.S., Yuan B., Jia H. Involvement of the frontal ventrolateral orbital cortex in descending inhibition of nociception mediated by the periaqueductal gray. Neurosci. Lett. 1997, 224:142-146.
53. Zhang S., Tang J.S., Yuan B., Jia H. Inhibitory effects of electrical stimulation of ventrolateral orbital cortex on the rat jaw-opening reflex. Brain Res. 1998, 823:359-366.
54. Zhang S., Tang J.S., Yuan B., Jia H. Inhibitory effects of glutamate-induced activation of thalamic nucleus submedius are mediated by ventrolateral orbital cortex and periaqueductal gray in rats. Eur. J. Pain 1998, 2:153-163.
55. Zhang S., Tang J.S., Yuan B., Jia H. Electrically-evoked inhibitory effects of the nucleus submedius on the jaw-opening reflex are mediated by ventrolateral orbital cortex and periaqueductal gray matter in the rat. Neuroscience 1999, 93:867-875.
56. Zimmermann M. Ethical guideline for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.